|
Select the type of credit certificate:
|
|
|
| CFMC will send by email, a certificate
of credit to each attendee who completes an evaluation form.
Please type name and degree(s) exactly as you wish them to
appear on the certificate (including letter case and punctuation). |
|
|
|
|
|
|
|
|
|
|
|
Please evaluate this session by selecting the button that best
describes your rating.
|
| Rate how well each objective has been met for you: | Poor Excellent | |
|
Discuss new developments in treatment of glaucoma, particularly with respect to medications.
|
|
|
|
Describe how surgical tools such as capsular tension rings and iris expansion rings are used in complex cataract surgery.
|
|
|
|
Discuss ethical issues in the ophthalmic practice, including surgical comanagement and appropriate interaction with pharmaceutical representatives.
|
|
|
|
Explain how cataract surgery impacts upon common retinal diseases and factors the surgeon should consider.
|
|
|
|
Discuss diagnosis and treatment options for retinal diseases and conditions.
|
|
|
|
Describe how practices and procedures within an ophthalmic office affect the quality of care given and ways in which these factors increase or reduce risk of malpractice.
|
|
|
|
List ways in which proper coding and chart documentation play a role in the management and quality of patient care.
|
|
|
|
Summarize how phacoemulsification cataract surgery is being taught in a third world country (Vietnam) and the potential benefits for this method over others.
|
|
|
|
| Rate the Teaching Effectiveness for each presenter: | Poor Excellent | |
|
Nisha Acarya, MD, MS
|
|
|
|
Neil Bressler, MD
|
|
|
|
Steven V.L. Brown, MD
|
|
|
|
John Doane, MD
|
|
|
|
Richard Fiscella, RPh, MPH
|
|
|
|
Steven Gedde, MD
|
|
|
|
Michael Henrick, JD
|
|
|
|
Marian Macsai, MD
|
|
|
|
Anne Menke
|
|
|
|
Joy Newby, LPN
|
|
|
|
Thomas Oetting, MD
|
|
|
|
Michael R. Redmond, MD
|
|
|
|
Mary Lou Schmidt, MD
|
|
|
|
|
|
|
Not
Likely |
|
|
|
Highly
Likely |
|
|
| To
what extent did you gain the following? |
Low |
|
|
|
High |
|
|
|
|
|
|
|
|
|
Very
Little |
|
|
|
Great
Deal |
|
|
|
|
|
|
| Commercial Support and Relationships: |
|
|
|
|
|
|
| Thank you for your
participation! |